News & Updates

Adding the PD-1/CTLA-4 bispecific antibody cadonilimab to chemotherapy improves overall survival (OS) and progression-free survival (PFS) in individuals with untreated, HER2-negative, locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) cancer, including patients with PD-L1–low tumours, according to the interim results of the phase III COMPASSION-15 trial.

Habitual intake of green kiwifruit may effectively relieve abdominal pain and constipation in adults with constipation-predominant irritable bowel syndrome (IBS-C), findings from a study presented at DDW 2024 suggest.

Bariatric surgery (BS), particularly sleeve gastrectomy, contributes to the improvement of disease-specific outcomes in patients with inflammatory bowel disease (IBD) and obesity, reports a study.

Hematochezia and abdominal pain are strong indicators of colorectal cancer (CRC), with the likelihood of CRC increasing by up to six- and 54-fold in the presence of such symptoms, according to a meta-analysis.

Increased body weight variability (BWV) contributes to adverse liver outcomes in people with type 2 diabetes (T2D) and metabolic dysfunction-associated steatotic liver disease (MASLD), a study has found. However, physical activity may attenuate such risk.